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Abstract: Dietary patterns may play an important role in musculoskeletal well-being. However,
the link between dietary patterns, the components of patients’ diet, and chronic musculoskeletal pain
remains unclear. Therefore, the purpose of this review was to systematically review the literature
on the link between dietary patterns, the components of patients’ diet and chronic musculoskeletal
pain. This review was conducted following the “Preferred Reporting Items for Systematic reviews
and Meta-Analyses” (PRISMA) guidelines and was registered in PROSPERO with the registration
number CRD42018110782. PubMed, Web of Science, and Embase online databases were searched.
After screening titles and abstracts of 20,316 articles and full texts of 347 articles, 12 eligible articles were
included in this review, consisting of nine experimental and three observational studies. Seven out of
nine experimental studies reported a pain-relieving effect of dietary changes. Additionally, protein,
fat, and sugar intake were found to be associated with pain intensity and pain threshold. In conclusion,
plant-based diets might have pain relieving effects on chronic musculoskeletal pain. Patients with
chronic rheumatoid arthritis pain can show inadequate intake of calcium, folate, zinc, magnesium,
and vitamin B6, whilst patients with fibromyalgia can show a lower intake of carbohydrates, proteins,
lipids, vitamin A-E-K, folate, selenium, and zinc. Chronic pain severity also shows a positive relation
with fat and sugar intake in osteoarthritis, and pain threshold shows a positive association with
protein intake in fibromyalgia.
Keywords: chronic pain; musculoskeletal pain; nutrition; diet; dietary pattern
1. Introduction
In recent decades, understanding of chronic (musculoskeletal) pain has evolved from a biomedical
perspective to a broader approach [1]. It has become evident that chronic musculoskeletal pain has
a significant bi-directional relation with various psychological, cognitive, and social factors such as
pain catastrophising, kinesiophobia, depression, and anxiety [2–4]. Recently, lifestyle factors such as
poor sleep, smoking, stress, unhealthy diet, and obesity/overweight, are gaining more attention for
chronic pain management [5–8]. It has been proposed that one or a combination of such intrinsic and
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extrinsic factors can change the neuronal organisation in the peripheral and central nervous system,
leading towards increased sensitivity of the central nervous system (i.e., central sensitization) in
musculoskeletal pain conditions such as non-specific chronic lower back pain (NCLBP), osteoarthritis,
fibromyalgia, and chronic fatigue syndrome [9–14]. Because these influencing factors are highly
individual, it becomes obvious that the experience of persistent pain differs from person to person even
under the same biological and pathological conditions. Thus, in order to deliver more comprehensive
healthcare, these factors should be considered as part of diagnosing and delivering individually tailored
multimodal treatment.
The World Health Organisation (WHO) also acknowledges the importance of diet, “Nutrition
is coming to the fore as a major modifiable determinant of chronic disease, with scientific evidence
increasingly supporting the view that alterations in diets have strong effects (both positive and negative)
on health throughout life” [15]. In general, nutrition is an essential part of musculoskeletal health. It has
a supportive effect in bone, as well as in cartilage structure and immune modulation [16]. For instance,
endogenous pain-relieving systems in the central nervous system require essential fatty acids such as
eicosapentaenoic acids, arachidonic acids, and tryptophan [17,18]. These essential fatty acids cannot
be synthesized by mammals and need to be derived from food intake. Additionally, vitamin D and
calcium intake have been reported as an essential factor for bone health [19], and effects of dietary
protein intake on muscle and bone health have been established as well [20]. However, although it is
well known that nutrition is an essential part of general musculoskeletal health, it is uncertain how
nutritional factors interact with chronic musculoskeletal pain.
Dietary behaviour and dietary intake are lifestyle factors that might influence the occurrence,
maintenance, and perception of chronic musculoskeletal pain [21–23]. For instance, overweight and
obesity are suggested as two main associated factors of unhealthy dietary behaviour and are two
main aspects of nutritional status in patients with chronic musculoskeletal pain [24]. Overweight
and obesity often occur due to nutrition related underlying mechanisms and are both common
comorbidities of chronic musculoskeletal pain disorders such as fibromyalgia [25,26], osteoarthritis [27],
chronic lower back pain (CLBP) [28], carpal tunnel syndrome [29], and pelvic pain [30]. They are
suggested as risk factors for developing chronic musculoskeletal pain [6]. Prevalence of having
chronic musculoskeletal pain increases as body mass index (BMI) raises [6]. Pain severity can show
direct relation with overweight and obesity in patients with osteoarthritis [31], lower back pain [32],
and fibromyalgia [33,34]. Thus, dietary behavioural change in overweight and obese patients is
suggested as an important aspect of pain management [26].
Furthermore, there are some studies that investigate the link between specific nutrients and chronic
pain. For instance, it has been reported that chronic lower back pain is associated with low vitamin D
intake [35]. Additionally, pain relieving effects of alkaline mineral [36] and omega-3 polyunsaturated
fatty acid [37] supplementation have been reported in patients with lower back pain and rheumatoid
arthritis, respectively. Moreover, inadequate intake of selenium was found to be associated with pain
severity in patients with fibromyalgia, and antioxidant intake was suggested for pain reduction in the
same population [38]. However, besides focusing on the effects of single nutrient intake on a specific
condition, the consideration of the overall dietary intakes of individuals is suggested as well.
Research on applied diets and dietary patterns considers a dietary evaluation in which overall
nutrients and food are examined instead of evaluating a single nutrient or food. This is a natural
approach, given that in a diet, nutrients and foods eaten together do not act in isolation, but rather
show synergistic effects [39]. Thus, dietary patterns and overall diet analysis are more robust way
of understanding diet–disease relationship [40,41]. For instance, assessment of dietary patterns is
suggested as an important indicator of chronic low-level systemic inflammation, which is an associated
factor of chronic diseases [42]. Adherence to a healthy dietary pattern, such as the Mediterranean
diet, is inversely associated with blood inflammatory biomarker levels [43,44]. An anti-inflammatory
diet with a lower dietary inflammatory index score relates to a higher (i.e., healthier) score on the
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Healthy Eating Index–2010 [45,46]. Thus, dietary patterns and overall diet is suggested as an effective
therapeutic target for chronic diseases [42].
In sum, diet and dietary patterns are important factors of musculoskeletal health and are
suggested as associated factors of musculoskeletal pain. However, it is uncertain how the dietary
patterns and components of patients’ diet are associated and interact with chronic musculoskeletal
pain. Moreover, to date, there is no clear literature overview bringing together the existing evidence on
the association between dietary patterns, components of patients’ diet, and chronic musculoskeletal
pain. This overview could give indications of how to include dietary advice in clinical practice
for the management of chronic musculoskeletal pain. Therefore, the purpose of this study is to
systematically review the existing literature on the link between nutrition and chronic musculoskeletal
pain by specifically focusing on dietary patterns, the components of patients’ diet, and pain in patients
diagnosed with chronic musculoskeletal pain.
2. Methods
2.1. Protocol and Registration
This systematic review was conducted and reported in line with the “Preferred Reporting Items
for Systematic reviews and Meta-Analyses” (PRISMA) guidelines [47]. The review protocol was
registered in the PROSPERO database (https://www.crd.york.ac.uk/prospero/) with the registration
number CRD42018110782.
2.2. Search Strategy and Eligibility Criteria
The search strategy was based on the Patient, Exposure, Comparison, Outcome (PECO) framework
(P = people with chronic musculoskeletal pain; E = (behavioural) nutrition; C = non-comparison or
comparison with a healthy, pain-free population; O = chronic musculoskeletal pain-related outcomes).
Inclusion Criteria
- Studies including adult human volunteers (above 18 years old);
- Having at least 3 months of musculoskeletal pain or musculoskeletal system-originated chronic
pain (i.e., chronic musculoskeletal pain);
- Studies that solely investigate the link between nutrition and pain, and do not include any other
treatment modality in experimental studies;
- Studies written in English and published in internationally peer-reviewed journals;
- Study types considered were randomised controlled trials, clinical trials (all phases), cohort
studies, case–control studies, and cross-sectional studies.
2.3. Information Sources and Keywords
The literature search conducted searches using three online databases: PubMed, Web of Science,
and Embase by two reviewers (O.E. and S.T.Y.) independently up to 1 October 2018.
Two groups of keywords were combined: “Chronic Musculoskeletal Pain (Patients)” and
“Nutrition (Exposure)”. Search terms used in PubMed, Web of Science, and Embase are stated
in the Supplementary Materials Section.
2.4. Study Selection
Study selection was performed independently by the same two researchers who were blinded
to each other (O.E. and S.T.Y.) on the basis of two screening phases. Firstly, titles and abstracts
of the search results were checked. Secondly, full texts of possibly relevant articles were checked.
Additionally, backward and forward tracking was performed as part of the search strategy. Backward
tracking includes screening of the reference lists of relevant articles (i.e., all included studies in the
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present systematic review as well as other relevant systematic reviews), whereas forward tracking
includes searching for studies that cited the studies that were included in the present systematic
review. A consensus meeting was organized between the two researchers after every step in the study
selection process, where discrepancies between selected studies were discussed. In case of doubts or
disagreements between researchers, a third and fourth researcher (A.M. and T.D.) were consulted to
make a final decision.
2.5. Data Extraction
The following information was extracted from each included paper by two reviewers (O.E. and
S.T.Y.) who were blinded to each other: (1) authors, (2) specific chronic musculoskeletal pain condition,
(3) study design and duration, (4) participant information, (5) intervention or case group, (6) control
group, (7) outcome measures, and (8) findings. All details are listed in Table 1.
2.6. Deviation from the Protocol
With reference to the protocol registered in PROSPERO (https://www.crd.york.ac.uk/prospero/) [48]
with the registration number CRD42018110782, this systematic review aimed to focus on nutrition
as a general aspect. Therefore, the scope of the search included all aspects of the nutrition research
such as macronutrients, micronutrients, foods, food groups, dietary supplements, diet analysis, dietary
patterns, applied diets, dietary behaviour, etc. Yet, this focus resulted in 149 eligible articles with
evidence on the link between nutrition (dietary patterns, dietary supplements, specific nutrients,
intravenous nutrient therapy, intramuscular vitamin injection, etc.) and chronic musculoskeletal pain.
However, a review including that many papers with a broad nutritional focus would decrease
readability and comprehensibility. Additionally, besides focusing on the effects of single nutrient
intake on a specific condition, we aimed to consider overall dietary intakes of individuals as well.
Research on dietary patterns considers a dietary evaluation in which overall nutrients and foods are
examined instead of evaluating a single nutrient or food. This is a natural approach, given that in a
diet, nutrients and foods eaten together do not act in isolation, but rather show synergistic effects [39].
Therefore, the scope of this systematic review was narrowed down to studies that investigate any link
between dietary patterns, components of patients’ diet, and chronic musculoskeletal pain conditions.
2.7. Risk of Bias Assessment
The methodological quality of each included study was assessed by two assessors independently
(O.E. and S.T.Y.). Risk of bias was assessed using the Cochrane Collaboration’s tool for randomised
controlled trials, the standard quality assessment criteria for evaluating primary research for
non-randomised controlled trials and uncontrolled clinical trials (QUALSYST), and the Newcastle
Ottawa scale (NOS) for observational studies. A consensus meeting was held between the two reviewers
to discuss possible differences in methodological quality scores. In case of doubts or disagreements
between these two reviewers, a third researcher (A.M.) was consulted to make a final decision.
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Table 1. Data extraction table.
Author (Year)
(Reference) and
Condition
Design and
Duration
Participant
Number (Female),
Age, Body Mass Index
Intervention (or Case) Group ControlGroup
Outcome
Measures Findings
Observational Studies
Batista et al.
(2016) [49]
and
FB
CC
FB: 43 (43 F)
49 ± 7.92
26.96 ± 4.64
C: 44 (44 F)
46.8 ± 10.36
25.72 ± 3.76
Three-day dietary record was used
to find out intake of total calories,
carbohydrates, lipids, vitamins (A, C,
B12, D, and K), and minerals (folate,
selenium, zinc, iron, calcium, and
magnesium).
Additionally, in order to investigate
the association between nutrient
intake and pain severity, pain
pressure threshold was used, and
measurement area was right
trapezius muscle.
Healthy people
Three-day
food diary
PPTs
Healthy control group showed
significantly higher caloric intake
and intake of carbohydrates,
proteins, lipids, vitamin A, vitamin
E, vitamin K, folate, selenium, and
calcium. There was no significant
difference in intake of iron.
Additionally, there was only a
significant positive correlation
between protein intake and pain.
Choi et al. (2014)
[50]
and
OA
CS
OA: 54 (49 F)
62.7 ± 9.3
32.6 ± 4.8
Two-day dietary record used in
order to measure the food intake of
patients. Additionally, VAS pain
scale used in order to assess the pain
intensity and its relationship with
food and nutrient intake.
No control group Food diaryVAS
Among obese or overweight OA
patients who have chronic pain, pain
severity is positively correlated with
calorie and fat intake. Patients who
have severe pain reported more
intake of sugar and fat.
Hejazi et al.
(2011) [51]
and
RA
CS
I: 90 (90 F)
47.47 ± 13.68
23.9 ± 1.59
Patients’ dietary and nutrient intakes
were analysed and compared with
the standard dietary reference intake
values.
No control group
Three-day
food diary
VAS
Intake of energy and micronutrients
including calcium, folic acid, zinc,
magnesium, and vitamin B6 were
considerably lower compared with
the dietary reference values. On the
other hand, intake of protein, copper,
and vitamin E met or exceeded the
recommended dietary reference
value in most of the patients.
Pain severity did not show any
significant correlation with any
nutrient intakes.
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Table 1. Cont.
Author (Year)
(Reference) and
Condition
Design and
Duration
Participant
Number (Female),
Age, Body Mass Index
Intervention (or Case) Group ControlGroup
Outcome
Measures Findings
Interventional Studies
Bellare et al.
(2014) [52]
and
OA
RCT
and
1 year
I: 61 (50 F)
59.98 ± 8.81
27.36 ± 3.71
C: 56 (40 F)
60.70 ± 8.31
27.68 ± 3.03
Weight loss diet alone and with
supplement:
Intervention group, diet, and
supplement group were
supplemented with glucosamine
(1500 mg) and chondroitin (1200 mg)
sulphate per day, in addition to the
same diet therapy as diet-only group
(weight lose diet).
Control group and diet-only group
received weight loss diet which is a
balanced energy-controlled diet
supplying 1200–1400 kcal per day
(carbohydrate 50%–55%, protein
15%–25%, fat < 30%).
Weight loss diet
alone
VAS (0 to 10)
WOMAC pain
A total of 16 patients from diet-only
group and 12 patients from diet and
supplementation group withdrew.
Both diet-only and diet with
supplement group showed
significant decrease in pain after 6
months and 1 year (p ≤ 0.05).
However, pain better improved
according to the VAS and WOMAC
scores in the supplement group after
1 year. Additionally, in the first 6
months, improvements in pain were
faster than the second 6 months.
Holst-Jensen
(1998) [53]
and RA
RCT
and
6 months
I: 15 (10 F)
Mean age = 56 (range 34–70)
BMI = NR
C: 15 (14 F)
Mean age = 46 (range 29–72)
BMI = NR
eptide diet: Patients were explained
the artificial elemental diet and were
given a commercialised liquid diet
(TU). The liquid diet contained soy
protein, methionine, tryptophan,
vitamins, and trace elements. The
diet lasted 4 weeks and then patients
were followed for 6 months in total
from the baseline until the end.
During the peptide diet, patients
were not allowed to eat and drink
any other foods or beverages except
for water and plain soda water.
Normal food
intake VAS (0 to 10)
A total of 2 and 1 patients withdrew
from the intervention and control
group, respectively.
Pain now, average pain, and worst
pain during the last week were
measured. Only average pain during
the last week significantly improved
after the 4 weeks of intervention
from 5(1.4/7.0) to 4(1.4/6.6) (p = 0.02).
However, this effect disappeared at
the 3 month follow up, and there
was no between-group differences.
Riecke et al.
(2010) [54]
and
OA
RCT
and
16 weeks
I: 96 (78 F)
61.8 ± 6.4
37.5 ± 5.4
C: 96 (77 F)
63.3 ± 6.3
37.1 ± 4.1
Very low energy diet: Patients (BMI
> 30 kg/m2) were expected to follow
a very low energy diet (415 kcal/day)
in the intervention group and were
expected to follow a low energy diet
(810 kcal/day) in the control group
for 8 weeks. After that, both groups
followed a hypo-energetic diet (1200
kcal/day) for a second 8 weeks.
Low-energy diet VAS (0 to 100)
A total of 10 patients from the very
low energy diet group and 7 patients
from the low energy diet group
withdrew.
Pain significantly decreased in both
groups after 16 weeks, with a pooled
average for pain 9.72 (95% CI:
7.72–11.72; p < 0.001). However,
there were no significant difference
between the groups.
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Table 1. Cont.
Author (Year)
(Reference) and
Condition
Design and
Duration
Participant
Number (Female),
Age, Body Mass Index
Intervention (or Case) Group ControlGroup
Outcome
Measures Findings
Sköldstam,
Larsson, and
Lindström
(1979) [55]
and
RA
RCT
and
10 weeks
I: 16 (10 F)
Mean Age = 52 (range = 35–66)
BMI = NR
C: 10 (9 F)
Mean age = 54 (range = 43–65)
BMI = NR
Fasting and lactovegetarian diet:
After fasting for 7–10 days,
participants followed a
lactovegetarian dietary pattern for
the following 9 weeks with a 1 week
resting period between fasting and
vegetarian diet.
During fasting, daily energy supply
was 800 kJ. During the
lactovegetarian period, no animal or
fish protein, egg, alcohol, tobacco,
coffee, or tea allowed.
Normal diet VAS (0 to 10)
One patient during the fasting and
one patient during the vegetarian
diet withdrew from the study.
After fasting, only five patients
showed significant improvement in
pain. However, there was no
significant difference in pain after
the lactovegetarian dietary pattern.
Vellisca and
Latorre (2014)
[56]
and
FB
RCT
and
3 months
I: 36 (36 F)
42.33 ± 8.43
NR
C: 36 (36 F)
39.64 ± 8.16
NR
Monosodium glutamate and
aspartame eliminated diet: Patients
were educated to detect and
eliminate the monosodium
glutamate and aspartame from their
diet. They were expected to follow
this diet for 3 months.
Normal diet NPRS (0 to 7)
Monosodium glutamate and
aspartame eliminated diet did not
show a significant effect compared to
normal dietary pattern (p = 0.178).
Kaartinen et al.
(2000) [57]
and
FB
NCT
and
3 months
I: 18 (18 F)
mean age = 51
mean BMI = 28
C: 15 (15 F)
mean age = 52
mean BMI = 28
Vegan diet: Patients were educated
to prepare their diet according to the
rules of the dietary pattern for 3
months. After 3 months, they
continued their normal omnivorous
diet, the diet that they wanted to
follow.
Omnivorous Diet VAS
The results revealed significant
improvements in visual analogue
scale of pain after 3 months of vegan
diet (p = 0.005). However, this
significant improvement
disappeared after shifting to
omnivorous diet gradually.
Marum et al.
(2017) [58]
and
FB
UCT
and
8 weeks
I: 38 (38 F)
mean age = 51
27.4 ± 4.6
A low fermentable
oligo-di-monosaccharides and
polyols (FODMAP) diet: Subjects
were educated according to the
FODMAP diet and were expected to
follow this diet as an intervention for
8 weeks.
No control group VAS (0 to 10)
Seven participants withdrew from
the study.
Pain measurement showed a
statistically significant decrease after
the fourth week. This significance
did not exist between the fourth and
eighth week. However, compared to
baseline, pain significantly decreased
after 8 weeks (week 0 = 6.6, week 4 =
4.9, week 8 = 5.4) (p < 0.01).
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Table 1. Cont.
Author (Year)
(Reference) and
Condition
Design and
Duration
Participant
Number (Female),
Age, Body Mass Index
Intervention (or Case) Group ControlGroup
Outcome
Measures Findings
McDougall et al.
(2002) [59]
and
RA
UCT
and
4 weeks
I: 24 (23)
56 ± 11
NR
Very low fat vegan diet: Four
meetings held in order to teach a
low-fat vegan diet to the participants.
They were expected to follow a
low-fat vegan diet for 4 weeks. The
diet contained no animal products or
added fats and oils of any kind.
No control group VAS (0 TO100)
No one withdrew from the study.
Pain significantly decreased
compared to baseline from 49 ± 20 to
34 ± 20 (p < 0.04).
Towery et al.
(2018) [60]
and
MSK
UCT
and
8 weeks
I: 14 (12 F) 48.07 ± 16.92
36.13 ± 10.45
Lacto-ovo vegetarian diet: Patients
have been given an education on
plant-based diet and were expected
to follow this dietary pattern for 8
weeks. Meat, poultry, seafood, and
fish were not allowed.
No control group
NPRS (0 TO
10)
SF-36 pain
No drop outs.
Pain rating significantly decreased
with an average of 3.14 point in
NPRS (p = 0.0001). Pain rate in SF-36
significantly decreased an average of
25.53 points (p = 0.0001).
MSK, musculoskeletal pain; FB, fibromyalgia; OA, asteoarthritis; RA, rheumatoid arthritis; RCT, randomised controlled trial; NCT, non-randomised controlled trial; UCT, uncontrolled
clinical trial; CC, case control study; CS, cross sectional study; C, control group; I, intervention group; PPTs, pressure pain threshold; VAS, visual analogue scale; WOMAC, The Western
Ontario and McMaster Universities Index; NPRS, numerical pain rating scale; BMI, body mass index; Kcal, kilo calorie; Mg, milligram; NR, not reported; F, female.
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3. Results
3.1. Study Selection
A flowchart giving a detailed overview of the study selection process can be found in Figure 1.
From the initial search of the online databases, PubMed, Web of Science, and Embase, 20,316 potentially
eligible articles were identified. After removing the duplicates, titles, and abstracts of 16,687 articles
were screened and 347 articles were found eligible for full text screening. A total of 149 articles
investigated the link between nutrition and chronic musculoskeletal pain conditions, of which 11
focused on overall diet analysis and dietary patterns. Backward and forward tracking resulted in one
extra article. Finally, 12 articles were found eligible to be included in the present systematic review.
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3.2. Study Characteristics
Key data from the included studies are shown in Table 1. The 12 eligible papers included five
randomised controlled trials [52–56], one non-randomised controlled trial [57], three uncontrolled
clinical trials [58–60], one case–control study [49], and two cross-sectional studies [50,51].
In total, four different chronic musculoskeletal pain conditions were studied: osteoarthritis
(n = 3) [50,52,54], rheumatoid arthritis (n = 4) [51,53,55,59], fibromyalgia (n = 4) [49,56–58], and general
musculoskeletal pain (n = 1) [60].
Investigated types of dietary patterns in the experimental studies included weight loss diet
(n = 2) [52,54], peptide diet (n = 1) [53], aspartame eliminated diet (n = 1) [56], vegetarian diet
(n = 2) [55,60], vegan diet (n = 2) [57,59], and FODMAP (low fermentable oligo-di-mono saccharides
and polyols) diet (n = 1) [58]. Additionally, in the three observational studies [49–51], dietary patterns
of patients were obtained, and characteristics of these patterns were explored.
3.3. Risk of Bias Assessment
Details of the risk of bias assessment are illustrated in Tables 2–4. Using the Cochrane
Collaboration’s tool, only one of the five randomised controlled trials was rated as having good
quality [52–56], one was rated as fair quality [53], and three were scored as poor quality [52,55,56].
Using the QUALSYST tool for non-randomised controlled trials and uncontrolled clinical trials,
two studies scored 0.90 [58,60], whereas two other studies were rated as 0.73 and 0.79 on the total score
of 1.00 [57,59]. Using the Newcastle Ottawa risk of bias assessment tool, both cross-sectional studies
were rated with five out of seven stars [50,51]. The only case–control study in this review was scored
with seven out of nine stars [49].
Table 2. Risk of bias assessment of randomised controlled trials (n = 5).
Author (Year)
Selection Bias PerformanceBias
Detection
Bias
Attrition
Bias
Reporting
Bias Other Bias Total
Random
Sequence
Generation
Allocation
Concealment
Blinding of
Participants
and Personnel
Blinding of
Outcome
Assessment
Incomplete
Outcome
Data
Selective
Reporting
Anything
Else, Ideally
Prespecified
Good
Fair
Poor
Bellare et al.
(2014) [52] Unclear Unclear High High Unclear Low Poor
Riecke et al.
(2010) [54] Low Low Low Low Low Low Good
Holst-Jensen
(1998) [53] Low Low Unclear Unclear Low Low Fair
Sköldstam,
Larsson, and
Lindström (1979)
[55]
Unclear Unclear Unclear Unclear High Low Poor
Vellisca and
Latorre (2014)
[56]
Unclear Unclear Unclear Unclear Low Low Poor
Selection Bias
- Criterion 1: Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence.
- Criteria 2: Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment.
Performance Bias
- Criterion 1: Performance bias due to knowledge of the allocated interventions by participants and personnel during the study.
Detection Bias
- Criterion 1: Detection bias due to knowledge of the allocated interventions by outcome assessors.
Attrition Bias
- Criterion 1: Attrition bias due to amount, nature, or handling of incomplete outcome data.
Reporting Bias
- Criterion 1: Reporting bias due to selective outcome reporting.
Other Bias
- Criterion 1: Bias due to problems not covered elsewhere in the table.
J. Clin. Med. 2020, 9, 702 11 of 23
Table 3. Risk of bias assessment of non-randomised controlled and uncontrolled clinical trials.
ASSESSMENT CRITERIA Non-Randomised
Controlled Trials Uncontrolled Clinical Trials
Kaartinen et al.
(2000) [57]
Marum et al.
(2017) [58]
Towery et al.
(2018) [60]
McDougall et al.
(2002) [59]
1. Question/objective sufficiently described? YES YES YES YES
2. Study design evident and appropriate? YES YES PARTIAL PARTIAL
3. Method of subject/comparison group
selection or source of information/input
variables described and appropriate?
PARTIAL YES YES YES
4. Subject (and comparison group, if applicable)
characteristics sufficiently described? YES YES YES YES
5. If interventional and random allocation was
possible, was it described? NO N/A N/A N/A
6. If interventional and blinding of
investigators was possible, was it reported? NO N/A N/A PARTIAL
7. If interventional and blinding of subjects
was possible, was it reported? N/A N/A N/A N/A
8. Outcome and (if applicable) exposure
measure(s) well defined and robust to
measurement/misclassification bias? Means of
assessment reported?
YES YES YES YES
9. Sample size appropriate? PARTIAL PARTIAL PARTIAL PARTIAL
10. Analytic methods described/justified and
appropriate? YES YES YES YES
11. Some estimate of variance is reported for
the main results? YES YES YES PARTIAL
12. Controlled for confounding? PARTIAL YES YES PARTIAL
13. Results reported in sufficient detail? YES YES YES YES
14. Conclusions supported by the results? YES YES YES YES
TOTAL 0.73 0.90 0.90 0.79
Table 4. Risk of bias assessment of case–control and cross-sectional studies.
Author (Year) and Study
Design Selection Comparability
EXPOSURE for Case Control
Studies/or OUTCOME for
Cross Sectional Studies
Total
Stars
S1 S2 S3 S4 C1 C2 E1/O1 E2/O2 E3
Choi et al. (2014) [50]
and cross-sectional * * - N/A * * - * N/A 5/7
Hejazi et al. (2011) [51]
and cross-sectional * * * N/A * * - * N/A 5/7
Batista et al. (2016) [49]
and case–control * - * * * * * * - 7/9
Selection
- S1 for case–control studies; is the case definition adequate?
- S1 for cross-sectional studies; representativeness of the sample.
- S2 for case–control studies; representativeness of the cases.
- S2 for cross-sectional studies; non-respondents.
- S3 for case–control studies; selection of the controls.
- S3 for cross-sectional studies; ascertainment of the exposure.
- S4 for case–control studies; definition of the control.
Comparability
- C1 for case–control studies; study controls for most important factor.
- C1 for cross-sectional studies; study controls for most important factor.
- C2 for case–control studies; study controls for any additional factors.
- C2 for cross-sectional studies; study controls for any additional factors.
Exposure
- E1; ascertainment of exposure.
- E2; same method of ascertainment of cases and controls.
- E3; non-response rate.
Outcome
- O1; assessment of outcome.
- O2; statistical analysis.
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3.4. Results of Individual Studies
This systematic review included nine experimental studies and three observational studies.
The results of the individual studies are explained below in detail.
Results from Experimental Studies: Effects of Dietary Pattern Change (i.e., Intervention) on Chronic
Musculoskeletal Pain
(1) Vegetarian Diet
Two studies investigated the effect of a vegetarian diet on chronic musculoskeletal pain [55,60].
A randomised controlled trial including people with rheumatoid arthritis (n = 16) applied a
lactovegetarian diet for 9 weeks following a 7 to 10 day fasting period instead of the normal,
omnivorous diet [55]. During the fasting period, patients were given 800 kcal obtained from 3 litres of
fruit and vegetable juices. Participants were not allowed to consume animal or fish protein (including
eggs), alcohol, tobacco, coffee, or tea. Intake of salt, sugar, white flour, fresh milk, and cream were
also discouraged.
Although five people with rheumatoid arthritis showed a significant improvement in visual
analogue scale (VAS) pain score compared to baseline measurements after the fasting period, there
was no statistically significant improvement in pain after the implementation of the lactovegetarian
diet compared to the control group [55].
The second study was an uncontrolled clinical trial that focused on the effect of a lacto-ovo
vegetarian diet on pain in people with general chronic musculoskeletal pain [60]. This diet consisted of
grains, fruits, vegetables, legumes, dairy products and eggs. However, participants were not allowed
to eat meat, poultry, seafood, or fish. Processed food and beverages were also discouraged. After an 8
week lacto-ovo vegetarian diet, participants showed significant improvements in pain, as measured by
both the numerical pain rating scale (NPRS) and the Short Form 36 (SF-36) pain score compared to
baseline measurement [60].
In conclusion, there was some evidence that the implementation of a lacto-ovo vegetarian diet
might be effective in decreasing pain in patients with general chronic musculoskeletal pain (level
of evidence C and strength of conclusion 3). Conversely, there was some evidence that a lacto-ovo
vegetarian diet has no effect on pain in patients with rheumatoid arthritis (level of evidence B and
strength of conclusion 3) (please see Tables 5 and 6 for level of evidence and conclusion).
Table 5. Level of evidence.
Level of Evidence Intervention
A1 Systematic review of at least two studies conductedindependently from each other of evidence level A2.
A2 Randomised double-blinded comparative clinicalresearch of good quality and efficient size
B
Comparative research, but not with all characteristics
mentioned for A2. This also includes patient– control
research and cohort research.
C Non-comparative research.
D Opinion of experts.
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Table 6. Level of conclusion.
Level of Conclusion Conclusion Based on
1 Research of evidence level A1 or at least twoindependently conducted studies of evidence level A2.
2 One research of evidence level A2 or at least twoindependently conducted studies of evidence level B.
3 One research of evidence level B or C.
4 Opinion of experts or inconclusive or inconsistent resultsbetween various studies.
(2) Vegan Diet
Two studies used the vegan diet as dietary pattern intervention [57,59]. First, a non-randomised
controlled trial compared a 3 month vegan diet with an omnivorous diet for its effect on pain in
people with fibromyalgia [57]. In this study, participants followed one form of vegan diet consisting of
uncooked foods, fruits, berries, vegetables, mushrooms, nuts, seeds, legumes, and cereals (living food).
The VAS pain score decreased significantly in response to the 3 month vegan diet compared to the
omnivorous diet. Moreover, this significant improvement in pain disappeared gradually immediately
after shifting back to the omnivorous diet [57].
The second study was an uncontrolled clinical trial including people with rheumatoid arthritis
who changed their regular diet to a low-fat vegan diet for 4 weeks [59]. The low-fat vegan diet
contained no animal products or added fats and oils of any kind. Compared to baseline measurements,
the VAS pain score showed a significant improvement in response to the low-fat vegan diet [59].
In conclusion, there was some evidence that a vegan diet might alleviate chronic musculoskeletal
pain (level of evidence B and strength of conclusion 3).
(3) Weight Loss Diet
Two studies examined the effect of a weight loss diet on pain [52,54]. The first randomised
controlled trial reported a significant decrease in VAS and Western Ontario and McMaster Universities
Osteoarthritis Index (WOMAC) pain scores in people with osteoarthritis in response to a hypo-energetic
(1200–1400 kcal/day) diet compared to baseline values after 6 months and 1 year [52]. The second
randomised controlled study compared a very low energy diet (415 kcal/day) to a low energy diet
(810 kcal/day) in osteoarthritis pain [54]. After 8 weeks of intervention, both groups followed a
hypo-energetic diet (1200 kcal/day) for 8 more weeks. It was reported that, although there was no
significant difference between groups, both groups showed significant improvements in VAS pain
score [54].
In conclusion, there was moderate evidence that a hypo-energetic diet might decrease pain severity
in patients with chronic osteoarthritis pain (level of evidence A2 and strength of conclusion 2).
(4) Peptide Diet
In a randomised controlled trial, the effect of a (commercialised) liquid peptide diet on rheumatoid
arthritis pain was investigated [53]. Daily caloric intake of the participants was adjusted to the 30 kcal/kg
individually. Participants were not allowed to eat and drink anything else during the 4 week liquid
peptide diet except for (soda) water. The average VAS pain score improved significantly after 4 weeks
of dietary intervention, but this improvement disappeared at the 3 months follow-up from the end of
the 4 weeks of intervention.
In conclusion, there was limited evidence that the liquid peptide diet might decrease pain severity
in the short term, but not in the long term, in patients with rheumatoid arthritis (level of evidence B
and strength of conclusion 3).
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(5) Monosodium Glutamate and Aspartame Eliminated Diet
One randomised controlled study investigated the effect of a 3 month monosodium glutamate and
aspartame eliminated diet in people with fibromyalgia compared with a normal dietary pattern [56].
Participants in the intervention and control group did not show any significant difference in numerical
pain rating score.
In conclusion, there was no evidence that a diet without monosodium glutamate and aspartame
has an effect on chronic musculoskeletal pain in patients with fibromyalgia (level of evidence B and
strength of conclusion 3).
(6) FODMAP Diet
In an uncontrolled clinical trial, people with fibromyalgia followed a low fermentable
oligo-di-monosaccharides and polyols (FODMAP) diet for 8 weeks [58]. After the intervention,
VAS pain scores significantly decreased.
In conclusion, there was weak evidence that a FODMAP diet might alleviate pain severity in
patients with fibromyalgia (level of evidence B and strength of conclusion 3).
Results from observational studies: Dietary pattern characteristics of patients with chronic
musculoskeletal pain.
This systematic review included three observational studies: one case–control study, and two
cross-sectional studies. The case–control study compared the dietary pattern characteristics and
pressure pain thresholds of people with fibromyalgia with healthy, pain-free participants by using a 3
day food diary [49]. Results showed that, compared to the healthy pain free group, the dietary patterns
of people with fibromyalgia had a significantly lower caloric intake and intake of carbohydrates,
proteins, lipids, vitamin A, vitamin E, vitamin K, folate, selenium, and calcium. There was no significant
difference in intake of iron. Regarding the association between pain and diet, a significant positive
correlation was found between protein intake and pressure pain thresholds among patients with
fibromyalgia (Spearman correlation coefficient = 0.358 and p = 0.018).
The first cross-sectional study analysed the dietary patterns of people with rheumatoid arthritis
by using a 3 day food diary and comparing it with dietary reference intake values [51]. Additionally,
associations between VAS score of pain and nutrient intake were considered. Results of the dietary
pattern analysis indicate that the intake of energy and micronutrients including calcium, folic acid, zinc,
magnesium, and vitamin B6 were considerably lower in people with rheumatoid arthritis compared to
the dietary reference values. On the other hand, in most of the patients, intake of protein, copper, and
vitamin E met or exceeded the recommended dietary reference value [61]. Importantly, pain severity
did not show any significant association with nutrient intake.
The second cross-sectional study used the VAS pain score and a 2 day food diary in people with
osteoarthritis [50]. Among obese and overweight people with osteoarthritis who had chronic pain,
pain severity was positively associated with calorie and fat intake. Patients having severe pain (VAS
pain score > 7) reported significantly more intake of sugar and fat compared to those having low pain
severity (VAS pain score between 0 to 2).
To conclude, observational studies mainly evaluated the nutritional status of the patients with
chronic musculoskeletal pain by comparing their dietary patterns with the dietary patterns of healthy,
pain-free people or by comparing their data with nutritional reference values. To summarize, it is
suggested that the intake of energy, calcium, folic acid, zinc, magnesium, and B6 is lower than the
dietary reference values in patients with chronic rheumatoid arthritis pain [61] (level of evidence C
and strength of conclusion 3) and intake of calorie, proteins, carbohydrates, lipids, vitamin A, vitamin
K, folate, selenium, and calcium is lower in patients with chronic fibromyalgia pain compared to
the nutritional intake of healthy, pain-free people (level of evidence B and strength of conclusion 3).
Pain threshold was also found to be positively associated with protein intake in patients with chronic
fibromyalgia, and pain severity was found to be positively associated with the intake of sugar and fat
in patients with chronic osteoarthritis pain (level of evidence B and strength of conclusion 3).
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4. Discussion
The aim of this systematic review was to investigate the association between dietary patterns and
chronic musculoskeletal pain conditions. The search strategy led to the inclusion of 12 papers, including
nine experimental and three observational studies. Four main approaches were used to investigate
the association between dietary patterns and chronic musculoskeletal pain: (1) the effects of a specific
dietary pattern intervention on pain in patients with chronic musculoskeletal pain; (2) comparing the
dietary patterns and nutritional intakes of patients having chronic musculoskeletal pain with those
of healthy, pain free-controls; (3) comparing dietary patterns and nutrient intakes of patients with
chronic musculoskeletal pain with standard dietary reference intake values; and (4) analysing the
dietary patterns of patients with chronic musculoskeletal pain cross-sectionally and investigating the
association between pain severity and food/nutrient intake.
Regarding the experimental studies, seven out of nine experimental studies reported improvement
in chronic pain in response to a specific diet [52–59]. These positive, pain-reducing diets included a
vegan diet for fibromyalgia [57] and rheumatoid arthritis [59], weight loss diet for osteoarthritis [52,54],
a vegetarian diet for general musculoskeletal pain [60], a FODMAP diet for fibromyalgia [58], and a
peptide diet for rheumatoid arthritis [53]. On the other hand, two studies out of nine did not find
any effect of a dietary pattern intervention on pain (i.e., the monosodium glutamate and aspartame
eliminated diet for fibromyalgia [56] and the vegetarian diet for rheumatoid arthritis [55]).
Among the studies that found positive effects of dietary changes on pain intensity, improvement
in pain may be explained because of an increase in healthy eating compared to the regular dietary
pattern. Four out of nine studies used a vegetarian or vegan diet. According to the Healthy Eating
Index-2010 and the Mediterranean diet score, which allow objectivation of overall diet quality [62],
these plant-based diets are considered more healthful compared to an omnivorous diet. Additionally,
according to the Dietary Inflammatory Index (DII) which was developed to measure the inflammatory
potential of specific foods and dietary constituents [63], plant-based dietary patterns are classified
as anti-inflammatory dietary patterns [64]. Therefore, more specifically, pain-relieving effects of
vegetarian and vegan diets might result from their anti-inflammatory characteristics. Chronic
inflammation is often suggested as one of the mechanisms underlying chronic musculoskeletal pain
disorders such as chronic low back pain [65], rheumatoid arthritis, fibromyalgia [66], myofascial pain
syndrome [67], osteoarthritis [68], and work-related overuse syndrome [69]. During the inflammatory
response, tissue releases several inflammatory biomarkers that activate nociceptors [70,71]. If the
presence of these inflammatory biomarkers persists beyond the normal healing time, this leads to
pain chronification due to prolonged peripheral sensitization, changes in peripheral and central
neuronal structure, and central sensitization [71,72]. To give an example, myofascial trigger points
defined as hyperirritable nodules within taut bands of skeletal muscle have been associated with
numerous musculoskeletal pain conditions such as myofascial pain syndrome [67], lower back pain [73],
neck pain [74], and fibromyalgia [75]. The active trigger points can cause an inflammatory response
and lead to release of inflammatory biomarkers at the surrounding muscles locally and even at the
remote uninvolved tissues [76]. Presence of this inflammatory response caused by active painful trigger
points can constitute a structural pathologic source of persistent nociception leading to peripheral and
central sensitization [77,78].
Vegetarian and vegan diets often consist of less protein, sugar, carbohydrate, and caloric intake
compared to an omnivorous diet, and are therefore more in line with dietary recommendations for
healthy eating [62]. Similar to Mediterranean and Palaeolithic diets, vegetarian and vegan diets are fruit
and vegetable-based dietary patterns and are inversely associated with the presence of inflammatory
biomarkers [44,62,79]. Conversely, a higher intake of protein, fat, sugar, and calories shows a positive
correlation with pain intensity and are characteristic features of the Western diet, which is associated
with chronic low-level inflammation [44], and thus with chronic pain and pain intensity [71].
It is also reported that compared to an omnivorous or Western style diet, plant-based diets such
as the vegetarian, vegan, and Mediterranean diets play important roles in protecting the stability and
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diversity of the gut microbiome [80]. The reason behind the interaction between plant-based diets
and healthy gut microbiome is the high proportion of some specific nutrients such as high amounts of
dietary fibre, mono- and polyunsaturated fatty acids, plant-derived proteins, and polyphenols [80].
There is a bi-directional relationship between the central nervous system and gut microbiota, which is
called the gut–central nervous system axis [81]. It is concluded that gut microbiome can cause
systemic inflammation and inflammation in the central nervous system, which can contribute to pain
chronification and amplification [81,82]. Therefore, the application of a more plant-based diets might
alleviate chronic musculoskeletal pain by their positive effects on gut microbiome and eventually on
systemic and central inflammation.
Available evidence shows that among obese or overweight osteoarthritis patients suffering from
chronic pain, higher pain severity is associated with higher calorie and fat intake, and patients with
severe pain reported greater intake of sugar and fat [50]. This might also explain the pain improvement
in the two randomised controlled studies that explored a calorie-restricted diet [52,54]. However, in
both studies, patients significantly lost weight after the calorie-restricted diet compared to baseline
measurements. Therefore, the decrease in BMI, more specifically decrease in fat mass, might also be
a reason for the pain decrease, as obesity itself can also negatively impact pain, given the low-level
chronic inflammation it may cause, as the adipose tissue can release proinflammatory cytokines [83].
Additionally, the decrease in fat mass and eventually in chronic inflammation might also lead to a
long-term pain-relieving effect on chronic musculoskeletal pain. This might constitute an effective
treatment modality for patients with chronic musculoskeletal pain who cannot reach adequate pain
relive effects with drugs and develop side effects [84,85].
Interestingly, in this review, we could not identify eligible studies that investigated the
Mediterranean diet. The Mediterranean diet comprises consumption of olive oil as a main source of
fat, as well as vegetables, fruits, legumes, cereals, and fish [86]. Compared to the Western diet, the
Mediterranean diet consists of more fibre [87], antioxidants [88,89], and α-linolenic acid [90], and less
linoleic acid [91,92], which probably gives it anti-inflammatory characteristics [92]. The pain-relieving
effect of this diet may be due to its anti-inflammatory effects. The Mediterranean diet shows an inverse
relation with the systemic inflammation level [93]—lower scores on the Mediterranean diet indicate a
pro-inflammatory dietary intake [43], and people who exhibit a higher adherence to the Mediterranean
Diet show lower scores on the dietary inflammatory index, which means that characteristics of their
diet are more anti-inflammatory [64,94]. There are some studies suggesting the Mediterranean diet as
reducing pain. For instance, in their systematic review, Forsyth et al. found evidence for pain reduction
among people with rheumatoid arthritis following the Mediterranean diet [95]. However, studies that
examined the Mediterranean diet as an intervention included both patients without pain syndrome
and patients with acute pain, and were therefore excluded from the present review [96].
Results from the included observational studies, in which dietary patterns of the patients were
analysed, mainly indicated that, among patients with chronic musculoskeletal pain, intake of nutrients
can be below the dietary reference values [51] and less than the nutritional intake of healthy, pain-free
people [49]. The intake of nutrients such as fat, sugar, and protein are associated with the severity of
chronic pain [49,50]. However, these findings differ among the chronic musculoskeletal pain conditions.
For instance, protein intake was associated with pain thresholds in fibromyalgia [49], whereas fat and
sugar intake were associated with pain severity in patients with chronic osteoarthritis pain [50].
Among patients with fibromyalgia, a significant positive association between protein intake and
pain threshold was reported [49]. Batista et al. reported a lower intake of carbohydrates, proteins, lipids,
vitamin A-E-K, folate, selenium, and zinc in patients with fibromyalgia compared to healthy women
without fibromyalgia [49]. As is reported in this study, inadequate protein intake might contribute to
the fibromyalgia pain by tryptophan deficiency, which might contribute to pain among patients with
fibromyalgia via the tryptophan-serotonin metabolism [38]. A positive association between protein
intake and pain threshold is another possible sign of association between protein malnutrition and pain
in fibromyalgia patients [49]. In their meta-analysis, Joustro et al. found that patients with fibromyalgia
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had significantly lower serum levels of vitamin E compared to healthy participants [97]. Therefore,
as Batista et al. reported, less vitamin E intake [49] and inadequate intake of certain vitamins and
minerals might play a role in the pathophysiology of fibromyalgia pain.
On the other hand, in patients with rheumatoid arthritis, pain severity did not show any significant
association with nutrient intake. It is suggested that patients diagnosed with rheumatoid arthritis who
have chronic pain have significantly less intake of calcium, folic acid, zinc, magnesium, and vitamin
B6 compared to reference values [51,61]. However, in patients diagnosed with rheumatoid arthritis,
it is possible that patients do not have chronic pain. Studies that included patients without chronic
pain were excluded from this review. Thus, in this group of patients, the appearance of pain and pain
severity might become less relevant with the dietary intakes because of the nature and underlying
mechanism of the disease.
4.1. Strengths and Limitations
There are several limitations to consider when reading this systematic review. A first limitation is
the generally low methodological quality of the included studies. Results discussed in this review
mainly relied on observational research, uncontrolled clinical trials, and non-randomised clinical trials.
Additionally, all included experimental studies were single-blinded, which means patients were aware
of the intervention. Selection of the participants was done according to the willingness of the patients
to participate. This increases the odds of selection bias, as it is possible that psychological factors
such as treatment expectations may play a role in explaining the observed pain relief in response to
dietary pattern changes. For instance, it was reported that the vegetarian diet is more effective on pain
reduction among patients with rheumatoid arthritis if the individuals expect that dietary change and
complementary therapies will improve their pain [98]
A second limitation is the heterogeneity of the participants’ characteristics. In total, five
different chronic musculoskeletal pain conditions were studied in the included studies. Therefore,
underlying pain-generating mechanisms might differ among various chronic musculoskeletal
conditions. For instance, although it was reported that fat and caloric intake is associated with
pain severity in patients with osteoarthritis [50], fat and caloric intake were not associated with pain
severity in patients with rheumatoid arthritis [51]. This might be due to different underlying pain
generator mechanisms [16]. On the other hand, the primary aim of this review was to show all possible
interactions between dietary pattern, components of patients’ diet, and chronic musculoskeletal pain.
Therefore, at this early stage of the new research line, inclusion of all the chronic musculoskeletal pain
conditions provides a more holistic view of the available literature on the link between nutritional
factors and chronic musculoskeletal pain.
A third limitation of this study is that, except for one study [49], assessments of pain as an outcome
was performed using self-reported unidimensional pain measurement tools such as VAS and NPRS.
Only one study used a pressure pain threshold algometer to measure the relation between dietary
intake and pain threshold [49]. Although these unidimensional scales are easily applicable and are
commonly used tools for measuring acute pain, multidimensional pain rating scales are suggested for
chronic pain [99]. VAS and NPRS depend on the patients’ experiences of pain, and are therefore highly
subjective [100]. Patients cannot be blinded to the assessment of the effects of the dietary interventions
on pain. Thus, it is possible that the overestimation of the patients might unconsciously contribute to
the results of the study [101].
Lastly, this study did not include a meta-analysis. Initially we intended to perform a meta-analysis.
However, due to the heterogeneity of the included studies, only qualitative analysis of the studies was
possible. Variety in study design, dietary intervention, and chronic musculoskeletal pain conditions
were major sources of study heterogeneity, precluding a meta-analytic approach to the available data.
Only five randomised controlled trials were included. These five studies consisted of three different
chronic musculoskeletal pain conditions and applied four different diet types as intervention [52–56].
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However, several strengths of this review are worth mentioning. First, this systematic review is
the first of its kind to investigate the relationship between dietary patterns, components of patients’
diet, and pain in patients with chronic musculoskeletal pain. Second, each step in this review, including
an online database search, study selection, risk of bias assessment, and data extraction, was performed
by two independent reviewers. This enabled the prevention of detection and performance bias. Third,
the systematic review was registered a priori in the PROSPERO database, and adhered to international
standards for the conducting and reporting of systematic reviews [47]. Finally, the systematic review
was supervised by an interdisciplinary team of researchers combining the necessary expertise from the
various fields needed to study the interaction between nutrition/diet and chronic pain.
4.2. Recommendations for Further Research
Most of the included studies were methodologically low in quality. Although there were five
randomised controlled trials included in this review, only one of them was rated as having a low risk
of bias. Therefore, more rigorous and high-quality clinical trials are urgently needed.
The heterogeneity of the studied chronic musculoskeletal pain conditions and variety in dietary
interventions made it impossible to have a clear view of the mechanisms that play a role in the
association between nutrition and pain. It is unfeasible to conduct a systematic review on a specific
musculoskeletal pain condition due to an insufficient number of researches in a specific musculoskeletal
pain group. Thus, more studies on each musculoskeletal pain condition are needed.
Studies that focus on the causal relation between systemic inflammation, chronic musculoskeletal
pain conditions, and dietary patterns are needed to explain the underlying mechanisms.
5. Conclusions
On the basis of the available literature, there is some evidence that plant-based dietary patterns
such as vegetarian and vegan diets might have pain-relieving effects on chronic musculoskeletal pain.
This effect might arise from the anti-inflammatory characteristics of the plant-based dietary patterns,
but studies exploring the mechanisms behind the pain-relieving effects of dietary interventions for
patients with chronic musculoskeletal pain are needed. There is also inconclusive evidence that patients
may show inadequate intake of calcium, folate, zinc, magnesium, and vitamin B6 in chronic rheumatoid
arthritis pain and a lower intake of carbohydrates, proteins, lipids, vitamin A-E-K, folate, selenium,
and zinc in chronic fibromyalgia pain compared to the reference values and data of healthy people,
respectively. Moreover, pain severity is positively associated with fat and sugar intake in chronic
osteoarthritis pain, and pain threshold is positively associated with protein intake. However, the
mechanisms behind this interaction are still uncertain, and more high-quality studies that investigate
the underlying mechanisms of the interaction between chronic musculoskeletal pain and nutrition
are needed.
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